Cargando…
Resolution of Pregabalin and Mirtazapine Associated Restless Legs Syndrome by Bupropion in a Patient with Major Depressive Disorder
Bupropion is a selective norepinephrine and dopamine reuptake inhibitor with no serotonergic activity, and is therefore an antidepressant with unique pharmacological properties. There are some reports that selective serotonin reuptake inhibitors (SSRIs) or mirtazapine can induce adverse effects incl...
Autores principales: | Park, Young-Min, Lee, Heon-Jeong, Kang, Seung-Gul, Cho, Jae-Hyuck, Kim, Leen |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Neuropsychiatric Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2808802/ https://www.ncbi.nlm.nih.gov/pubmed/20140131 http://dx.doi.org/10.4306/pi.2009.6.4.313 |
Ejemplares similares
-
Mirtazapine Aggravates Restless Leg Syndrome:A Case Report
por: Haldar, Prakash, et al.
Publicado: (2022) -
Association between Antipsychotics-Induced Restless Legs Syndrome and Tyrosine Hydroxylase Gene Polymorphism
por: Cho, Chul-Hyun, et al.
Publicado: (2009) -
Acute-Withdrawal Restless Legs Syndrome Following Abrupt Cessation of Short-Term Tramadol
por: Park, Young-Min, et al.
Publicado: (2014) -
The Safety and Efficacy of Pregabalin Add-on Therapy in Restless Legs Syndrome Patients
por: Bae, Hyoeun, et al.
Publicado: (2021) -
Bupropion and Iron for Restless Leg Syndrome: Do They Have Efficacy Similar to Ropinirole?
por: Praharaj, Samir Kumar
Publicado: (2017)